Henry Ford Health System
Henry Ford Health System
Detroit, Michigan, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fenofibrate for Prevention of DR Worsening | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-06-29 | NCT04661358 | |
| JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-04-16 | NCT02468024 | |
| Intraoral Hypothermia Device for Preserving Taste During Radiation | Head and Neck Neoplasms, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Taste Disorders, Taste Dysfunction, head and neck cancer, neoplasm, nervous system disorder | Recruiting | Early phase 1 | 2026-01-14 | NCT06579248 |